Becton Dickinson BDX
NYSE BDX
$179.09 -2.96 (-1.63%)
At close: Sep 30, 2026 · 4:00 PM EDT

Becton Dickinson (BDX) Income from Continuing Operations (2009 - 2026)

Updated

Becton Dickinson's Income from Continuing Operations was $451 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), unchanged from $451 million a year earlier.

Analysis

Becton Dickinson (BDX) Income from Continuing Operations (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Becton Dickinson's Income from Continuing Operations was $1.72 billion through Jun 30, 2026, up 31.0% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $1.68 billion, down 1.6% from FY2024.

  • Income from Continuing Operations shows a five-year compound annual growth rate of 36.7% (FY2020 to FY2025).
  • In earlier fiscal years, Income from Continuing Operations was $1.71 billion in FY2024 (+11.4%), $1.53 billion in FY2023 (-6.4%), $1.64 billion in FY2022 (+1.9%) and $1.6 billion in FY2021 (+355.7%).
  • Quarterly Income from Continuing Operations has moved between -$37 million (fiscal Q2 2026) and $923 million (fiscal Q4 2025) over five years.
  • Compared with a year earlier, Income from Continuing Operations was higher in four of the last seven quarters, with growth averaging 35.1%.
  • The best year-over-year quarter for Income from Continuing Operations over five years was fiscal Q4 2024 (growth of 159.7%); the worst was fiscal Q2 2025 (a decline of 70.6%).
  • Per Business Quant data, BDX's Income from Continuing Operations in the three fiscal quarters before Q3 2026 was -$37 million (Q2 2026), $382 million (Q1 2026) and $923 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 1.76 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 928.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 870.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 823.20 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 1.48 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -220.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 905.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 241.40 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 451.00 Mn
10 Agilent Technologies 48.58 Bn 41.47 Bn 1.04 Bn 362.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 451.00 Mn
Mar 31, 2026 -37.00 Mn
Dec 31, 2025 382.00 Mn
Sep 30, 2025 923.00 Mn
Jun 30, 2025 451.00 Mn
Mar 31, 2025 158.00 Mn
Dec 31, 2024 303.00 Mn
Sep 30, 2024 400.00 Mn
Jun 30, 2024 487.00 Mn
Mar 31, 2024 537.00 Mn
Dec 31, 2023 282.00 Mn
Sep 30, 2023 154.00 Mn
Jun 30, 2023 407.00 Mn
Mar 31, 2023 460.00 Mn
Dec 31, 2022 509.00 Mn
Sep 30, 2022 287.00 Mn
Jun 30, 2022 390.00 Mn
Mar 31, 2022 390.00 Mn
Dec 31, 2021 568.00 Mn
Sep 30, 2021 154.00 Mn
API Access

Becton Dickinson Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=BDX&period=max&api_key=YOUR_API_KEY